Company Profile

AVM Biotechnology LLC (AKA: Ave Maria Biotechnology LLC)
Profile last edited on: 4/26/2022      CAGE: 59W32      UEI: D29NFMS3DJJ8

Business Identifier: Stem cell-enabling technologies for regenerative medicine, immuno-oncology and fully human biologics applications.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1749 Dexter Avenue North
Seattle, WA 98109
   (206) 482-0913
Location: Single
Congr. District: 07
County: King

Public Profile

Formerly dba Ave Maria Biotechnology (LLC)., AVM Biotechnology is structured around development of stem cell technologies designed to offer treatment in the form of regenerative medicine, immuno-oncology, and iPS cell fully human biologics. The company's G-CSF induced stem cell mobilization, GvHD, germinal centre lymphomas and iPS cell lines human biologics are enabling medical practitioners to have access to medicines with minimum side effects. The most recentnews about the firm is thatthey have received FDA IND approval to test their lead product AVM0703 for treatment of lymphoid malignancies. The mechanism of action that makes AVM0703 work against aggressive cancers may also prove effective against COVID-19. To further that research, AVM Biotechnology has filed with the FDA for approval to proceed with clinical trials against this virus as well as Influenza virus which also causes deadly ARDS.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Theresa Deisher -- Founder & CEO/ Chairman

  Joe Luminiello -- Chief Executive Officer

  Michael Anderson -- Chief Administrative Officer

  Michael J Bernard -- Advisor & Microsoft U.S. Tax Counsel

  Manon Cox

  Terrence Kopp -- VP of Investor Relations

  Neil O'Connor -- CFO

Company News

There are no news available.